生物科技LOF(501009)利润分配表
|
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
收入 |
157,764,897.57 |
-515,528,102.84 |
-687,743,411.06 |
-341,698,234.18 |
利息合计 |
207,516.49 |
1,315,580.52 |
1,066,655.55 |
3,214,041.91 |
其中:存款利息收入 |
207,516.49 |
509,007.12 |
260,082.15 |
653,933.16 |
债券利息收入 |
- |
- |
- |
- |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
- |
3,704.79 |
3,704.79 |
- |
投资收益合计 |
-157,266,335.93 |
-203,383,262.54 |
-108,346,678.95 |
-273,458,489.62 |
其中:股票投资收益 |
-175,597,893.61 |
-240,703,056.97 |
-130,862,656.62 |
-311,101,935.39 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
83,263.05 |
90,905.22 |
44,739.71 |
1,698.08 |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
18,248,294.63 |
37,228,889.21 |
22,471,237.96 |
37,641,747.69 |
基金分红收益收益 |
- |
- |
- |
- |
公允价值变动收益 |
314,723,128.08 |
-313,854,548.51 |
-580,571,592.07 |
-71,817,201.45 |
其他收入 |
100,588.93 |
394,127.69 |
108,204.41 |
363,414.98 |
费用 |
12,044,566.54 |
25,827,421.52 |
13,311,602.69 |
32,819,905.31 |
管理人报酬 |
9,014,391.37 |
18,895,630.67 |
9,719,622.38 |
23,817,398.16 |
基金托管费 |
1,201,918.90 |
2,519,417.35 |
1,295,949.64 |
3,175,653.00 |
销售服务费 |
1,619,977.24 |
3,699,785.92 |
1,927,022.11 |
4,963,904.53 |
交易费用 |
- |
- |
- |
- |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
208,279.03 |
709,696.92 |
366,117.90 |
853,732.51 |
利润总额 |
145,720,331.03 |
-541,355,524.36 |
-701,055,013.75 |
-374,518,139.49 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年